Find insight on Fresnillo, the copper market, Australian mining, and more in the latest Market Talks covering Basic Materials ...

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced that Chief Executive Officer Marc Viscogliosi ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

Morgan Stanley reaffirmed Tesla as its top pick, maintaining a $430 price target despite mixed analyst ratings. Some firms, ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Canaccord Genuity Group reaffirmed their buy rating on shares of Science Group (LON:SAG – Free Report) in a research note published on Monday,Digital Look reports. Canaccord Genuity Group currently ...

While many of its peers abandon the lithium sector, Green Technology Metals is priming itself for development.

We recently compiled a list of the Wall Street Optimism Spills Over to These 10 Stocks on Friday. In this article, we are ...

Shares of DoubleVerify touched a record low after its full-year outlook missed Wall Street estimates, its fourth-quarter revenue came in lower than expected and two firms cut their target prices.

Fintel reports that on February 28, 2025, Canaccord Genuity downgraded their outlook for ICF International (NasdaqGS:ICFI) ...

Canaccord Genuity Sustainability Virtual Summit February 26, 2025 2:20 PM ETCompany ParticipantsRyan Corbett - Chief ...